<DOC>
	<DOCNO>NCT02403115</DOCNO>
	<brief_summary>The purpose study clarify mechanism involve formation glomerular deposition immune complex lupus nephritis . The determination antibody pattern specific systemic lupus erythematosus lupus nephritis may also role predict disease progression patient systemic lupus erythematosus without renal impairment . As patient enrol study , determination antibody pattern may contribute targeted personalized treatment , allow prediction disease progression introduction early target treatment , order block onset and/or progression renal damage .</brief_summary>
	<brief_title>Prediction Outcome Lupus Nephritis</brief_title>
	<detailed_description>Prospective multicenter study validity level circulate antibody glomerular neo-autoantigens ( alpha-enolase annexin AI ) implantable antigen ( anti-DNA , histone , istone3 , istone4 , C1q ) surrogate biomarker diagnosis lupus nephritis . The study involve collection serum patient lupus nephritis onset subsequent follow-up 6 , 12 , 24 36 month titration circulate autoantibody . As control investigator use serum patient systemic lupus erythematosus without nephropathy , collected time interval . The investigator also assess antibody positivity group patient rheumatologic disease similar lupus ( rheumatoid arthritis ) patient autoimmune nephropathy without extrarenal clinical sign . Regarding patient systemic lupus erythematosus investigator collect serum incident prevalent patient order monitor change antibody level conjunction development renal disease . Clinical test ( renal function , complete blood count , C reactive protein ( CRP ) , ANA , native DNA ( nDNA ) , urine analysis ) perform 6 , 12 , 24 36 month surplus blood sample use create serum bank study . Samples collect pediatric nephrology Giannina Gaslini Children Hospital , Genoa ( coordinator centre ) 5 rheumatological ( Genoa , Pisa , Pavia , Padova , Brescia ) 6 nephrological ( Milan , Genoa , Parma , Brescia , Bologna Reggio Emilia ) italian adults department .</detailed_description>
	<mesh_term>Lupus Erythematosus , Systemic</mesh_term>
	<mesh_term>Nephritis</mesh_term>
	<mesh_term>Lupus Nephritis</mesh_term>
	<criteria>Age 4 65 year Diagnosis lupus nephritissystemic lupus erythematosus ( systemic lupus erythematosus , rheumatoid arthritis membranous nephropathy control ) Informed consent Severe infection place Malignancies current history Chronic hepatitis B Virus ( HBV ) Hepatitis C Virus ( HCV ) positive Breastfeeding pregnant Known hypersensitivity drug</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>